EUVIMEDEUVIMED entdecken
Crossref

Mesenchymal stem/stromal cells alleviate early‐stage pulmonary fibrosis in a uPAR‐dependent manner

Anastasia Yu Efimenko, Anna A Shmakova, Vladimir S Popov, Natalia A Basalova, Maxim A Vigovskiy iD, Olga A Grigorieva, Veronika Yu Sysoeva, Polina S Klimovich, Nikita R Khabibullin, Vsevolod A Tkachuk, Kseniya A Rubina, Ekaterina V Semina

Cell Biology International · 2024-11 · 48 (11) · 1714-1730

DOI: 10.1002/cbin.12222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biology International, online erschienen am 18.07.2024. Verfasst von Anastasia Yu Efimenko und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russia. Hauptthemen laut MEDLINE: Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells, Pulmonary Fibrosis, Receptors, Urokinase Plasminogen Activator. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary fibrosis, a debilitating lung disorder characterised by excessive fibrous tissue accumulation in lung parenchyma, compromises respiratory function leading to a life‐threatening respiratory failure. While its origins are multifaceted and poorly understood, the urokinase system, including urokinase‐type plasminogen activator (uPA) and its receptor (uPAR), plays a significant role in regulating fibrotic response, extracellular matrix remodelling, and tissue repair. Mesenchymal stem/stromal cells (MSCs) hold promise in regenerative medicine for treating pulmonary fibrosis. Our study aimed to investigate the potential of MSCs to inhibit pulmonary fibrosis as well as the contribution of uPAR expression to this effect. We found that intravenous MSC administration significantly reduced lung fibrosis in the bleomycin‐induced pulmonary fibrosis model in mice as revealed by MRI and histological evaluations. Notably, administering the MSCs isolated from adipose tissue of uPAR knockout mice ( Plaur ‐/‐ MSCs) attenuated lung fibrosis to a lesser extent as compared to WT MSCs. Collagen deposition, a hallmark of fibrosis, was markedly reduced in lungs treated with WT MSCs versus Plaur ‐/‐ MSCs. Along with that, endogenous uPA levels were affected differently; after Plaur ‐/‐ MSCs were administered, the uPA content was specifically decreased within the blood vessels. Our findings support the potential of MSC treatment in attenuating pulmonary fibrosis. We provide evidence that the observed anti‐fibrotic effect depends on uPAR expression in MSCs, suggesting that uPAR might counteract the uPA accumulation in lungs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem Cell TransplantationMesenchymal Stem CellsPulmonary FibrosisReceptors, Urokinase Plasminogen ActivatorAnimalsMaleMiceBleomycinDisease Models, AnimalLungMice, Inbred C57BLMice, KnockoutUrokinase-Type Plasminogen Activator

Stichwörter der Autor:innen

mesenchymal stem/stromal cellspulmonary fibrosisurokinase receptor uPAR

Substanzen

BleomycinPlaur protein, mouseReceptors, Urokinase Plasminogen ActivatorUrokinase-Type Plasminogen Activator

Autor:innen und Institutionen

  • Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russia.
  • Institute for Regenerative Medicine, Lomonosov Moscow State University, Moscow, Russia.
  • Institut Gustave Roussy, Université Paris Saclay, UMR 9018, CNRS, Villejuif, France.
  • Institute of Experimental Cardiology, National Medical Research Centre of Cardiology Named after Academician E.I. Chazov, Moscow, Russia.

ORCID-Profile: Maxim A Vigovskiy

Förderung

  • Russian Science Foundation

Zitieren

APA

Efimenko, A. Y., Shmakova, A. A., Popov, V. S., Basalova, N. A., Vigovskiy, M. A., Grigorieva, O. A., Sysoeva, V. Y., Klimovich, P. S., Khabibullin, N. R., Tkachuk, V. A., Rubina, K. A., & Semina, E. V. (2024). Mesenchymal stem/stromal cells alleviate early‐stage pulmonary fibrosis in a uPAR‐dependent manner. Cell Biology International, 48(11), 1714-1730. https://doi.org/10.1002/cbin.12222

Vancouver

Efimenko AY, Shmakova AA, Popov VS, Basalova NA, Vigovskiy MA, Grigorieva OA, et al. Mesenchymal stem/stromal cells alleviate early‐stage pulmonary fibrosis in a uPAR‐dependent manner. Cell Biology International. 2024;48(11):1714-1730. doi:10.1002/cbin.12222

BibTeX
@article{Efimenko2024,
  author = {Efimenko, Anastasia Yu and Shmakova, Anna A and Popov, Vladimir S and Basalova, Natalia A and Vigovskiy, Maxim A and Grigorieva, Olga A and Sysoeva, Veronika Yu and Klimovich, Polina S and Khabibullin, Nikita R and Tkachuk, Vsevolod A and Rubina, Kseniya A and Semina, Ekaterina V},
  title = {Mesenchymal stem/stromal cells alleviate early‐stage pulmonary fibrosis in a uPAR‐dependent manner},
  journal = {Cell Biology International},
  year = {2024},
  volume = {48},
  number = {11},
  pages = {1714--1730},
  doi = {10.1002/cbin.12222}
}
Kostenlos starten →